|
Introduction
Cotinine residues are produced as the liver metabolises nicotine that has been inhaled or otherwise taken into the body. This can result from smoking (either active or passive), or from the medication used in nicotine-withdrawal therapy.
Once we know the levels of cotinine residue present in the body, we can evaluate the subject's smoking habits and draw up appropriate counter-measures designed to break his or her habit.
health4u AG offers a product, developed and tested in North America by Nymox Pharmaceutical Corporation ( www.nymox.com), for the detection of cotinine in the body: NicAlert™.
|